Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Next-generation biomaterials to help body heal itself

08.02.2002


The next generation of biomaterials will help the body heal itself by prompting cells to repair their own tissues, scientists report today.



Writing in a review in the journal Science, Professors Larry Hench and Julia Polak of Imperial College, London, highlight the potential of `third generation` biomaterials that activate specific cells and genes of the individual they are implanted into.

Pioneering work by the two authors recently led to the discovery of a family of bone formation genes that can be regulated by bioactive materials. This discovery is already being used to create a new generation of biomaterials for regeneration and repair of tissue.


The authors also signal a new era in biomaterials, calling for research emphasis to shift from replacement to regeneration of tissues.

Professor Hench, discoverer of Bioglass (R) and author of a 1980 Science review of the field, said:

"The advantage of the new approach is that the body`s own genes control the tissue repair process. The result is equivalent to natural tissues in that the new structure is living and adaptable to the physiological environment. It is the scientific basis for us to design a new generation of gene-activating biomaterials tailored for specific patients and disease states."

In the last two years a group at Imperial College Tissue Engineering Centre headed by Professor Polak has analysed how human cells behave when they are attached to scaffolds of a specific bioactive material.

They demonstrated that key genes of bone cells involved in bone formation are activated when a bioactive material designed and configured for the purpose of bone formation is brought together with it. At the same time other genes, normally activated when fat or other tissues are formed, were down regulated.

"In the future we may only need to implant the carefully calculated chemical ingredients of the biomaterial, rather than a `finished` biomaterial itself, in order to repair tissue," said Professor Hench.

"By designing these very specific molecular scaffolds for repair of tissues and using minimally invasive surgery to implant them, this technique could have a major clinical application."

"Perhaps of even more importance is the possibility that bioactive stimuli can be used to activate genes in a preventative treatment to maintain the health of tissues as they age," he said.

Their review tracks the development of the field from the 1960s to the present day, in a special edition of the journal on the `Bionic Human.`

In the 1960`s and 1970`s, the first generation of biomaterials was developed for use inside the human body. A key feature of these biomaterials is their biological inertness, which minimises the body`s response to the foreign body. The authors estimate that tens of millions of individuals have had their quality of life enhanced for 5 to 25 years through such implants.

In 1984 a major shift began with a second generation of materials that become activated in a controlled way when implanted in the body. `Bioactive` materials such as glasses, ceramics and composites have since been used in a variety of orthopaedic and dental applications. `Resorbable` biomaterials that are slowly broken down and replaced by regenerating tissues appeared at the same time.

However the authors state that survivability rates of skeletal prostheses and artificial heart valves show that a third to half of prostheses fail within 10-25 years, meaning that many patients require revision surgery.

The article is one of 9 reports on the topic `Bodybuilding: The Bionic Human`, covered in Science this week.


For more information please contact:

Professor Larry Hench
Department of Materials and Imperial College Tissue Engineering Centre
Tel: +44 (0)20 7594 6745
Email: l.hench@ic.ac.uk

Professor Julia Polak
Imperial College Tissue Engineering Centre
Tel: +44 (0)20 8237 2670
Email: julia.polak@ic.ac.uk

Tom Miller
Imperial College Press Office
Tel: +44 (0)20 7594 6704
Mob: +44 (0)7803 886248
Email: t.miller@ic.ac.uk

Tom Miller | alphagalileo

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data storage using individual molecules

Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.

Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Pressure tuned magnetism paves the way for novel electronic devices

18.12.2018 | Materials Sciences

New type of low-energy nanolaser that shines in all directions

18.12.2018 | Physics and Astronomy

NASA research reveals Saturn is losing its rings at 'worst-case-scenario' rate

18.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>